Research Article
CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway
Table 2
Correlation analysis of CCL3 expression and clinical data in human colorectal cancer tissue.
| Group | n | CCL3 expression | χ2 | | High | Moderate | Low | Loss |
| Gender | Male | 26 | 5 | 14 | 6 | 1 | 3.559 | 0.313 | Female | 24 | 3 | 16 | 2 | 3 | Age | ≤60 years | 19 | 3 | 14 | 1 | 1 | 5.949 | 0.114 | >60 years | 31 | 5 | 15 | 8 | 3 | Tumor site | Rectum | 22 | 2 | 16 | 4 | 0 | 5.785 | 0.123 | Colon | 28 | 6 | 13 | 5 | 4 | TNM stage | I | 14 | 1 | 4 | 8 | 1 | 18.442 | 0.005 | II | 17 | 4 | 9 | 3 | 1 | III | 19 | 4 | 13 | 0 | 2 | Differentiation (grade) | Well | 7 | 0 | 4 | 2 | 1 | 9.95 | 0.127 | Moderate | 30 | 6 | 18 | 4 | 2 | Poor | 13 | 7 | 4 | 1 | 1 | Lymph-vascular space invasion | Present | 16 | 3 | 9 | 3 | 1 | 0.73 | 0.886 | Absent | 34 | 5 | 20 | 6 | 3 | Perineural invasion | Present | 22 | 3 | 16 | 3 | 0 | 5.165 | 0.16 | Absent | 28 | 5 | 13 | 6 | 4 |
|
|